iShares V Plc (IHCU) S&P 500 Health Care Sector UCITS ETF GBP

The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the S&P 500 Capped 35/20 Health Care Index, the Fund’s benchmark index. The Share Class, via the Fund, invests in equity securities (e.g. shares) that, so far as possible and practicable, make up the benchmark index. The benchmark index measures the performance of stocks from the S&P 500 Index which are within the Global Industry Classification Standard (GICS) health care sector. The S&P 500 measures the performance of 500 stocks from top US companies in leading industries of the US economy which meet S&P’s size, liquidity and free-float criteria. The GICS health care sector currently encompasses two main industry groups. The first includes companies who manufacture health care equipment and supplies or provide health care related services, including distributors of health care products, providers of basic health-care services, and owners and operators of health care facilities and organisations. The second group includes companies primarily involved in the research, development, production and marketing of pharmaceuticals and biotechnology products. The benchmark index may not include and/or may not be limited to every category comprising the sector listed here. Companies are included in the benchmark index on a free float-adjusted market capitalisation weighted basis. Free float-adjusted means that only shares available to international investors, rather than all of a company’s issued shares, are used to calculate the benchmark index.   The benchmark index caps the weight of the largest companies at each rebalance to ensure index diversification. The weight of the largest group entity in the benchmark index is capped at 33% and the remaining group entities at 19%. Your shares will be accumulating shares (i.e. income will be included in their value).

• Leverage -
• Currency hedgingNo

• Value Assessment review date31 March 2025
• Value Assessment next review date -
• Is Assessment of Value required under COLL?No
• Outcome of COLL Assessment of Value -
• Outcome of PRIN Value Assessment or reviewProduct expected to provide fair value for reasonably foreseeable period
• Other review related to value and or charges -
• Further information-